World Vol.101 (U.S., etc.)

World Vol.98 (U.S., etc.)

World Vol.97 (U.S., finance, etc.)

World Vol.88 (U.S., Canada, Australia, New Zealand, etc.)

World Vol.82 (U.S. Presidential Inauguration Day – Australia)

World Vol.78 (U.S., etc.)

World Vol.71 (U.S. – Chaos in Washington D.C.) / Washington D.C. Vol.5

World Vol.64 (U.K., U.S., etc.)

UK Vol.175 (Coronavirus, Brexit, 2019, etc.)

Preparations for a Brexit IV: views from Austria, the Czech Republic, Finland, Greece, and Malta (05/27/2016) | @LSE

Switzerland Vol.10 (corporations: ABB Group, Glencore, LafargeHolcim)

World Vol.62 (U.S., Australia, Canada, France, Spain, Sweden, etc.)

Benelux Vol.5 (Netherlands Vol.11 / Belgium Vol.6 / Luxembourg Vol.2)

UK Vol.174 (quality & safety solutions corporations: Intertek)

Science and Technology Vol.49

World Vol.58 (U.S., Australia, etc.)

World Vol.56 (U.S., etc.)

World Vol.55 (incl 2019)

UK Vol.173 (pharmaceutical corporations: Seqirus) / Australia Vol.30

cf. Pennsylvania Vol.11 (corporations: CSL Behring) / Australia Vol.29

Our Story | CSL

Fluad In-Season | Seqirus US
Seqirus Begins Shipping 2020/21 Influenza Vaccines to U.S. Market (07/30/2020) |
A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age. | @nlm_news
Seqirus Announces U.S. FDA Approval of Its First-Ever Adjuvanted, Cell-Based Pandemic Influenza A (H5N1) Vaccine (02/03/2020) | @YahooFinance
First Adjuvanted Quadrivalent Influenza Vaccine by Seqirus Receives EU Approval (08/06/2020) | CISION
Seqirus announces Health Canada approval of first cell-based seasonal influenza vaccine (12/11/2019) | CISION
Seqirus Ships Northern Hemisphere Flu Vaccines (07/15/2019) | precision vaccinations
Human Vaccines Project and Seqirus partner to advance universal flu vaccine research (28/06/2018) | @EurekAlert
Joint media release from Invest Liverpool, the Mayor of Liverpool and Seqirus (25/02/2017) | Seqirus
CSL completes purchase of Novartis’ flu vaccine business (08/03/2015) | @FiercePharma

Belgium Vol.4 (pharmaceutical corporations: Janssen Pharmaceutica)

cf. New Jersey Vol.9 (corporations: Johnson & Johnson)

Science and Technology Vol.45

New Zealand Vol.22 (2020 Election)